New patent opposition
Doctors of the World has filed this monday 27th march a new patent opposition on Sofosbuvir. This patent is related to base compound that is used to produce the drug. This major patent protecting Sofosbuvir has been granted to Gilead in June 2016. MdM assume it does not comply with patentability requirements per defined by 1973 European Patent Convention.